HomeBOLT • NASDAQ
add
Bolt Biotherapeutics Inc
Previous close
$1.10
Day range
$1.04 - $1.12
Year range
$0.84 - $2.03
Market cap
41.94M USD
Avg Volume
120.69K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 2.09M | 48.05% |
Operating expense | 5.53M | -1.30% |
Net income | -17.90M | 10.47% |
Net profit margin | -857.01 | 39.53% |
Earnings per share | -0.47 | 11.32% |
EBITDA | -19.30M | 6.22% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 102.19M | -39.49% |
Total assets | 159.78M | -29.86% |
Total liabilities | 47.04M | -16.44% |
Total equity | 112.74M | — |
Shares outstanding | 38.13M | — |
Price to book | 0.37 | — |
Return on assets | -29.49% | — |
Return on capital | -35.04% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -17.90M | 10.47% |
Cash from operations | -14.26M | 20.54% |
Cash from investing | 15.81M | -3.81% |
Cash from financing | 106.00K | -26.39% |
Net change in cash | 1.65M | 220.17% |
Free cash flow | -6.00M | 49.90% |
About
Founded
2015
Headquarters
Website
Employees
100